Jubilant Pharmo (JUBLPHARMA)
STALWARTFairStock Score: 51/100 — MIXED
Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹946.3 |
| Market Cap | ₹13,800.16 Cr |
| P/E Ratio | 29.9 |
| ROCE | 9.54% |
| ROE | 6.92% |
| Dividend Yield | 0.58% |
| Profit Growth | -31.01% |
| Debt/Equity | 0.44 |
| Sales Growth | 12.09% |
| Free Cash Flow | ₹1,58,400 Cr |
| Promoter Holding | 47.67% |
| 52-Week Range | ₹786.05 — ₹1,248 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹392.65 |
Jubilant Pharmo trades with a P/E ratio of 29.9, ROCE of 9.54%, ROE of 6.92%, profit growth of -31.01%, debt-to-equity of 0.44. The FairStock Score of 51/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer